Evidence map›Paper›PMID 36744645›Full record

ArticleAnnals of clinical and translational neurology2023

PRNP expression predicts imaging findings in sporadic Creutzfeldt-Jakob disease.

Iris J Broce, Eduardo Caverzasi, Simone Sacco, Ryan Michael Nillo, Matteo Paoletti, Rahul S Desikan, Michael Geschwind, Leo P Sugrue

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Frontiers in neuroscience · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 4 countries.

Iris J BroceWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, UCSF, San Francisco, California, USA.ORCID 0000-0003-4932-1430
Eduardo CaverzasiWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, UCSF, San Francisco, California, USA.ORCID 0000-0002-0350-0460
Simone SaccoWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, UCSF, San Francisco, California, USA.ORCID 0000-0001-8789-3099
Ryan Michael NilloNeuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA.
Matteo PaolettiWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, UCSF, San Francisco, California, USA.
Rahul S DesikanNeuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA.
Michael GeschwindWeill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, UCSF, San Francisco, California, USA.
Leo P SugrueNeuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA.
University of California, San Francisco · USUniversity of San Diego · US

Funding

Predicting progression of human prion diseaseR01AG031189 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GESCHWIND, MICHAEL D · 2008 to 2017
$5.7M
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)R01AG062562 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GESCHWIND, MICHAEL D · 2019 to 2023
$5.4M
Elucidating clinical heterogeneity in early-onset AD via genomics, transcriptomics, and neuroimagingR01AG062588 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YOKOYAMA, JENNIFER S · 2019 to 2023
$4.0M
UCSD Leading the Advancement of Underrepresented Neuroscientists for Change (LAUNCH) Faculty Development ProgramR25NS117367 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Victoria B Risbrough, Joann Trejo · 2020 to 2026
$1.6M
Improving the Health of Aging Women and Men.T32AG058529 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LACROIX, ANDREA Z. · 2019 to 2023
$1.2M
Novel imaging genetic biomarkers for sporadic frontotemporal dementia through machine learningK01AG070376 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROCE-DIAZ, IRIS J · 2021 to 2025
$528k
Sex in Alzheimer diseaseR03AG063260 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YOKOYAMA, JENNIFER S · 2019 to 2020
$321k
NIA NIH HHS K01 AG070376NIA NIH HHS R01 AG031189NIA NIH HHS R01 AG062562NIA NIH HHS R01 AG062588NIA NIH HHS R03 AG063260NIA NIH HHS T32 AG058529NINDS NIH HHS R25 NS117367
6 · The paper itself

Abstract

objectiveWe explored the relationship between regional PRNP expression from healthy brain tissue and patterns of increased and decreased diffusion and regional brain atrophy in patients with sporadic Creutzfeldt-Jakob disease (sCJD).

methodsWe used PRNP microarray data from 6 healthy adult brains from Allen Brain Institute and T1-weighted and diffusion-weighted MRIs from 34 patients diagnosed with sCJD and 30 age- and sex-matched healthy controls to construct partial correlation matrices across brain regions for specific measures of interest: PRNP expression, mean diffusivity, volume, cortical thickness, and local gyrification index, a measure of cortical folding.

resultsRegional patterns of PRNP expression in the healthy brain correlated with regional patterns of diffusion signal abnormalities and atrophy in sCJD. Among different measures of cortical morphology, regional patterns of local gyrification index in sCJD most strongly correlated with regional patterns of PRNP expression. At the vertex-wise level, different molecular subtypes of sCJD showed distinct regional correlations in local gyrification index across the cortex. Local gyrification index correlation patterns most closely matched patterns of PRNP expression in sCJD subtypes known to have greatest pathologic involvement of the cerebral cortex.

interpretationThese results suggest that the specific genetic and molecular environment in which the prion protein is expressed confer variable vulnerability to misfolding across different brain regions that is reflected in patterns of imaging findings in sCJD. Further work in larger samples will be needed to determine whether these regional imaging patterns can serve as reliable markers of distinct disease subtypes to improve diagnosis and treatment targeting.

Indexed as

Creutzfeldt-Jakob SyndromePrionsAdultBrainHumansPrion ProteinsPrion ProteinsPrionsPRNP protein, human

Identifiers

PMID36744645
PMCPMC10109249
OpenAlexW4319294368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.